XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Cash flow provided by (used in) operating activities:    
Net income $ 459,297 $ 247,307
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Depreciation and amortization 53,938 46,700
Stock-based compensation 19,942 20,636
Income (Loss) from unconsolidated entities (28,313) (5,304)
Distributions of earnings from unconsolidated entities 30,716 17,996
Deferred tax (benefit) provision 6,956 14,804
Inventory impairments and write-offs 15,997 21,934
Gain (Loss) on Disposition of Assets (38,706) (12,970)
Other 1,984 (558)
Gain (Loss) on Extinguishment of Debt 35,211 0
Changes in operating assets and liabilities    
Inventory (578,461) (124,235)
Origination of mortgage loans (1,452,289) (1,191,066)
Sale of mortgage loans 1,498,946 1,250,109
Receivables, prepaid expenses and other assets 97,738 (172,790)
Income Taxes Receivable (11,233) 11,552
Customer deposits, net 163,440 47,222
Accounts payable and accrued expenses 173,524 (29,742)
Income taxes payable (259) 0
Net Cash Provided by (Used in) Operating Activities, Continuing Operations 448,428 141,595
Cash flow (used in) provided by investing activities:    
Purchase of property and equipment - net (45,772) (75,001)
Investments in and advances to unconsolidated entities (190,027) (47,310)
Return of investments in unconsolidated entities 166,045 42,639
Proceeds from sales of golf club property and an office building 80,418 15,617
Acquisition of a business 0 (60,349)
Other investing changes 649 885
Net Cash (Used in) Provided By Investing Activities, Continuing Operations 11,313 (123,519)
Cash flow used in financing activities:    
Proceeds from loans payable 2,164,646 3,250,010
Repayments of loans payable (2,381,509) (3,334,431)
Redemption of senior notes (294,168) 0
(Payments) proceeds from stock-based benefit plans 8,979 11,252
Purchase of treasury stock (275,058) (633,873)
Dividends paid (56,103) (42,650)
Proceeds from (Payments to) Noncontrolling Interests (4,710) (1,935)
Net Cash Used in Financing Activities, Continuing Operations (837,923) (751,627)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect (378,182) (733,551)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period 1,396,604 1,319,643
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period $ 1,018,422 $ 586,092